Editors' Picks from the World Press

Pipeline/RD News

• Alzheimer's drug Dimebon fails Phase III trial

Early data show Genzyme's muscular dystrophy drug failed goal

Business Finance

• Covidien starts selling generic version of painkiller Actiq
• Archimedes Pharma raises $98 million in financing round
• Bristol-Myers, Allergan strike licensing deal for pain drug
• Merck KGaA plans to move U.S. chemical unit to Massachusetts

Government Legal News

• Novo Nordisk gains FDA approval for growth hormone injection pen
• ACT's stem cell therapy gets orphan-drug status from FDA
• FDA panel will examine issue of defective insulin pumps
• FDA committee urges additional prosecution of food, drug execs